The Enterprise Value as of December 2024 (TTM) for Alkermes plc (ALKS) is 4.74B

According to Alkermes plc’s latest financial reports and current stock price. The company's current Enterprise Value is 4.74B. This represents a change of 8.61% compared to the average of 4.37B of the last 4 quarters.

Alkermes plc (ALKS) Historical Enterprise Value (quarterly & annually)

How has ALKS Enterprise Value performed in the past?

The mean historical Enterprise Value of Alkermes plc over the last ten years is 6.11B. The current 4.74B Enterprise Value has changed 7.67% with respect to the historical average. Over the past ten years (40 quarters), ALKS's Enterprise Value was at its highest in in the December 2015 quarter at 12.10B. The Enterprise Value was at its lowest in in the March 2020 quarter at 2.50B.

Alkermes plc (ALKS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Alkermes plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alkermes plc (ALKS) Average Enterprise Value

How has ALKS Enterprise Value performed in the past?

The current Enterprise Value of Alkermes plc (ALKS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Alkermes plc (ALKS) Enterprise Value vs. Peers

How is ALKS’s Enterprise Value compared to its peers?

Alkermes plc’s Enterprise Value is less than Intra-Cellular Therapies, Inc. (8.63B), greater than Ironwood Pharmaceuticals, Inc. (1.27B), greater than Deciphera Pharmaceuticals, Inc. (2.15B), greater than Pacira BioSciences, Inc. (1.29B), greater than ANI Pharmaceuticals, Inc. (1.62B), less than Dr. Reddy's Laboratories Limited (1.16T), greater than Collegium Pharmaceutical, Inc. (1.77B), greater than Eagle Pharmaceuticals, Inc. (19.21M), greater than Phibro Animal Health Corporation (1.10B), less than Prestige Consumer Healthcare Inc. (4.89B), less than Neurocrine Biosciences, Inc. (13.80B), greater than Dynavax Technologies Corporation (1.81B), greater than Amphastar Pharmaceuticals, Inc. (2.27B), greater than Evolus, Inc. (602.76M),

Build a custom stock screener for Alkermes plc (ALKS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alkermes plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alkermes plc (ALKS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alkermes plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.